Page 3 - Harvard Bioscience News Today

Operator: Thank you for standing by and welcome to the Harvard Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, todays program is being recorded.

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

The global Electrophoresis Reagents Market size was valued at USD 1.2 Billion in 2022 and is projected to attain USD 2.3 Billion by 2032 mounting at a CAGR of 6.7% from 2023 to 2032.

Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Free Report) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totalling 1,050,000 shares, a growth of 13.0% from the September 15th total of 928,900 shares. Currently, 2.7% of the shares of the stock are short sold. Based […]

The global microplate systems market is anticipated to grow at a considerable CAGR of 4.8% during the forecast period (2023-2030).

Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Free Report) saw a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 1,050,000 shares, a growth of 13.0% from the September 15th total of 928,900 shares. Based on an average daily volume of 136,800 shares, the short-interest ratio […]

It hasn't been the best quarter for Harvard Bioscience, Inc. ( NASDAQ:HBIO ) shareholders, since the share price has...

The global remote workforce management software market is anticipated to grow at a considerable CAGR of 11.4% during the forecast period (2023-2030).

Perfusion Systems Industry is projected to witness a CAGR of 4.6% during the period 2023-2032. This growth can be attributed to the increasing prevalence...